echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Coatings News > Paints and Coatings Market > Jinpu Titanium Industry: Subsidiary Xuzhou Titanium Dioxide resumes production

    Jinpu Titanium Industry: Subsidiary Xuzhou Titanium Dioxide resumes production

    • Last Update: 2022-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Jinpu Titanium Industry announced on the evening of April 17 that according to the epidemic prevention and control notice of the Xuzhou New Coronary Pneumonia Epidemic Prevention and Control Headquarters, the company's subsidiary Xuzhou Titanium Dioxide will park in an orderly and orderly manner from April 1, 2022
    .
    Now, according to the requirements of the latest notice and with the approval of higher-level government departments, Xuzhou Titanium Dioxide, a subsidiary of the company, will gradually resume work and production in an orderly manner since April 15
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.